Abcam
British biotechnology company
Updates & Highlights
simplywall.st · 13 days ago
How Investors May Respond To Danaher (DHR) Expanding AI-Driven R&D Integration Between Genedata And Abcam
AIM Media House · 13 days ago
Abcam Expands Genedata Partnership To Accelerate AI-Driven Antibody Development
marketscreener.com · 14 days ago
Abcam And Genedata Collaborate To Accelerate AI-Driven Antibody Development At Global Scale
Recent Openings
View all 1 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Health Insurance
Medical, dental & vision
Learning Budget
Professional development
Generous PTO
Paid time off
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Remote Work
Work from anywhere flexibility
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Abcam?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentHow Investors May Respond To Danaher (DHR) Expanding AI-Driven R&D Integration Between Genedata And Abcam
How Investors May Respond To Danaher (DHR) Expanding AI-Driven R&D Integration Between Genedata And Abcam
simplywall.st · 13 days ago
Abcam Expands Genedata Partnership To Accelerate AI-Driven Antibody Development
Abcam Expands Genedata Partnership To Accelerate AI-Driven Antibody Development
AIM Media House · 13 days ago
Abcam And Genedata Collaborate To Accelerate AI-Driven Antibody Development At Global Scale
Abcam And Genedata Collaborate To Accelerate AI-Driven Antibody Development At Global Scale
marketscreener.com · 14 days ago
Genedata Expands Abcam Antibody R&D Partnership
Genedata Expands Abcam Antibody R&D Partnership
Contract Pharma · 14 days ago
Abcam and Genedata Collaborate to Accelerate AI-Driven Antibody Development at Global Scale
Abcam and Genedata Collaborate to Accelerate AI-Driven Antibody Development at Global Scale
Yahoo Finance · 14 days ago
Abcam Number of Employees 2026 | Employee Count & Headcount Data
Abcam Number of Employees 2026 | Employee Count & Headcount Data
Revelio Labs · about 2 months ago
Abcam and EpiCypher Join Forces to Advance Epigenomics Research
Abcam and EpiCypher Join Forces to Advance Epigenomics Research
Laboratory Talk · about 2 months ago
Abcam and EpiCypher Partner to Advance High-Confidence Epigenomics Research
Abcam and EpiCypher Partner to Advance High-Confidence Epigenomics Research
BioPharma APAC · 2 months ago
Abcam and EpiCypher partner to develop ChIC/CUT&RUN reagents
Abcam and EpiCypher partner to develop ChIC/CUT&RUN reagents
Manufacturing Chemist · 2 months ago
ABCAM LIMITED Announces Termination of Markus Lusser as Director, Effective June 5, 2026
ABCAM LIMITED Announces Termination of Markus Lusser as Director, Effective June 5, 2026
marketscreener.com · 3 months ago
Abcam Launches Next-Gen ELISA, Wider Dynamic Range Delivers Results in Less Time
Abcam Launches Next-Gen ELISA, Wider Dynamic Range Delivers Results in Less Time
Contract Pharma · 5 months ago
Abcam launches SimpleStep Ignite™ ELISA: an innovative assay platform that combines 50x higher sensitivity and up to 35x wider dynamic range in only 55 minutes
Abcam launches SimpleStep Ignite™ ELISA: an innovative assay platform that combines 50x higher sensitivity and up to 35x wider dynamic range in only 55 minutes
Yahoo Finance · 5 months ago
Abcam wins three recognitions at the 2026 CiteAb Awards
Abcam wins three recognitions at the 2026 CiteAb Awards
Abcam · 6 months ago
Sustainability at Abcam: environmental commitment
Sustainability at Abcam: environmental commitment
Abcam · 6 months ago
Abcam joins LIGAND-AI project for AI drug discovery
Abcam joins LIGAND-AI project for AI drug discovery
Abcam · 8 months ago
Abcam joins the Innovative Health Initiative LIGAND-AI project to advance artificial intelligence (AI)-driven drug discovery through open science
Abcam joins the Innovative Health Initiative LIGAND-AI project to advance artificial intelligence (AI)-driven drug discovery through open science
PR Newswire · 8 months ago
How Abcam is leading the way in antibody performance
How Abcam is leading the way in antibody performance
Abcam · over 1 year ago
Danaher to acquire Abcam for $24.00 per share
Danaher to acquire Abcam for $24.00 per share
Abcam · over 1 year ago
Abcam to open office in Shanghai, China
Abcam to open office in Shanghai, China
Abcam · over 1 year ago
Abcam plc: FY2024 Guidance
Abcam plc: FY2024 Guidance
Abcam · over 1 year ago